- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made).
Statutory Instruments
Consumer Protection
Made
at 11.38 a.m. on 6th July 2023
Laid before Parliament
at 3.30 p.m. on 6th July 2023
Coming into force in accordance with regulation 1(2) and (3)
The Secretary of State makes these Regulations in exercise of the powers conferred by Article 31(1)(b) and 31(1)(d) of Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products(1).
1.—(1) These Regulations may be cited as the Cosmetic Products (Restriction of Chemical Substances) Regulations 2023.
(2) These Regulations, except regulation 2(2), come into force 21 days after the day on which they are made.
(3) Regulation 2(2) comes into force on 6th July 2024.
(4) These Regulations extend to England and Wales and Scotland.
2.—(1) Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products is amended as follows.
(2) At the end of the table in Annex 3 (list of substances which cosmetic products must not contain except subject to the restrictions laid down), insert the entry set out in Schedule 1 to these Regulations.
(3) At the end of the table in Annex 6 (list of UV filters allowed in cosmetic products), insert the entries set out in Schedule 2 to these Regulations.
3. Notwithstanding the amendment in regulation 2(2), a cosmetic product that is placed on the market prior to 6th July 2024 can continue to be made available on the market until 6th July 2026.
Kevin Hollinrake
Minister for Small Business, Consumers and Labour Markets
Department for Business and Trade
At 11.38 a.m. on 6th July 2023
Regulation 2(2)
“321 | Methyl-N-methylanthranilate | 85-91-6 | 201-642-6 | (a) Leave-on products | 0.1% | For leave on products only: Not to be used in sunscreen products and products marketed for exposure to natural or artificial UV light. | ||
(b) Rinse-off products | 0.2% | For leave-on and rinse-off products: | ||||||
| ||||||||
| ||||||||
|
Regulation 2(3)
“33 | 1,1’-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone | Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine | 919803-06-8 | 485-100-6 | 10% | In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %. | ||
34 | 1,1’-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone | Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano) | 919803-06-8 | 485-100-6 | 10% | Only anomaterials having the following characteristics are allowed: | ||
| ||||||||
| ||||||||
Not to be used in applications that may lead to exposure of the end user’s lungs by inhalation. | ||||||||
In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %. ” |
(This note is not part of the Regulations)
These Regulations amend retained EU legislation, Regulation (EC) No 1223/2009 (“the Cosmetics Regulation”) following advice from the Scientific Advisory Group on Chemical Safety on the safety of using Methyl-N-methylanthranilate and both HAA299 and HAA299 (nano) in cosmetic products.
Regulation 2 amends the technical annexes to the Cosmetics Regulation to restrict the use of Methyl-N-methylanthranilate and permit the use of HAA299 and HAA299 (nano) in cosmetic products.
Regulation 3 provides for transitional arrangements for cosmetics products containing Methyl-N-methylanthranilate and provides that where products were already placed on the market prior to 6th July 2024, they can continue to be made available on the market until 6th July 2026.
A full impact assessment has not been produced for this instrument as no, or no significant, impact on the private, voluntary or business sectors is foreseen. An Explanatory Memorandum has been published alongside these Regulations and is available at www.legislation.gov.uk.
EUR 1223/2009 was incorporated into domestic law by virtue of section 3(1) of the European Union (Withdrawal) Act 2018 (c. 16) with relevant amendments made by S.I. 2019/696, 2019/696 and 2022/659.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: